Biochemists report a way to stop the immortality of cancer cells with oligonucleotides

February 12, 2019, RUDN University
Credit: Natalia Deryugina

RUDN biochemists found a way to reduce the activity of telomerase (the enzyme of cell immortality) 10-fold. The discovery could lead to new antitumor drugs and give a better understanding of how the activity of the enzyme can be controlled. The results of the study were published in the journal Biochemical and Biophysical Research Communications.

The ends of chromosomes are covered with a kind of safety cap called telomeres. These are compact DNA sequences that stabilize the chromatin structure. With each cell division, telomeres become shorter, and the older a cell becomes, the shorter the telomeres of its chromosomes. However, certain types of cells (e.g. , , and lymphocytes) have an active immortality enzyme called telomerase. It compensates for the shortening of telomeres and allows the cells to divide practically endlessly. The highest telomerase activity is observed in —this is one of the factors that makes them malignant. RUDN biochemists demonstrated that the activity of telomerase may be reduced using specific oligonucleotides (short DNA fragments).

"We wanted to find out whether the oligonucleotides in charge of splicing shift are able to slow down the activity of telomerase (splicing is the process of cutting and reattaching of mRNA segments). We studied it in human T-lymphocytes. As a result, we managed to find an oligonucleotide able to suppress telomerase and slow down without killing the cells," said Dmitry Zhdanov, a co-author of the work, a candidate of biology, and assistant professor of Academician Beryozov Department of Biochemistry at RUDN.

The main way of influencing the activity of telomerase is inducing alternative splicing of its mRNA. As a result of this process, several non-active protein forms are synthesized in a cell. RUDN biochemists affected the using three types of oligonucleotides specific for different regulatory areas of telomerase mRNA. They were injected into human T-lymphocyte cells, and the activity of telomerase was measured after one day. It turned out that individual oligonucleotides did not influence the enzyme considerably, but the combination had a profound effect: the activity of telomerase reduced to 50 percent within the first 24 hours, to 18 percent within the second, and to 10 percent within the third.

According to the biochemists, oligonucleotides may serve as a basis for new drugs for anti-proliferative therapy that us used to treat benign and and other conditions associated with excessive .

Explore further: Biochemists described a new mechanism for autoimmunity suppression

More information: Dmitry D. Zhdanov et al, Inhibition of telomerase activity by splice-switching oligonucleotides targeting the mRNA of the telomerase catalytic subunit affects proliferation of human CD4+ T lymphocytes, Biochemical and Biophysical Research Communications (2019). DOI: 10.1016/j.bbrc.2018.12.186

Related Stories

Blocking two enzymes could make cancer cells mortal

May 17, 2018

EPFL scientists have identified two enzymes that protect chromosomes from oxidative damage and shortening. Blocking them might be a new anticancer strategy for stopping telomerase, the enzyme that immortalizes tumors.

Recommended for you

Archaeologists discover Incan tomb in Peru

February 16, 2019

Peruvian archaeologists discovered an Incan tomb in the north of the country where an elite member of the pre-Columbian empire was buried, one of the investigators announced Friday.

Where is the universe hiding its missing mass?

February 15, 2019

Astronomers have spent decades looking for something that sounds like it would be hard to miss: about a third of the "normal" matter in the Universe. New results from NASA's Chandra X-ray Observatory may have helped them ...

What rising seas mean for local economies

February 15, 2019

Impacts from climate change are not always easy to see. But for many local businesses in coastal communities across the United States, the evidence is right outside their doors—or in their parking lots.

The friendly extortioner takes it all

February 15, 2019

Cooperating with other people makes many things easier. However, competition is also a characteristic aspect of our society. In their struggle for contracts and positions, people have to be more successful than their competitors ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.